What is the ticker symbol for VivoSim Labs?

VivoSim Labs trades under the ticker VIVS on NASDAQ.

What sector does VivoSim Labs operate in?

VivoSim Labs is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze VIVS in a portfolio?

PortView shows VIVS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

VivoSim Labs (VIVS) Stock Analysis

NASDAQHealthcareBiotechnology

$0.27-1.94%

1-year price historyRange $0.27 – $4.78

52-week range$0.27

$0.26$5.30

What VivoSim Labs does

VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers partners liver and intestinal toxicology insights through its new approach methodologies (NAM) models; and bespoke services in the areas of investigational toxicology, mechanism of drug action elucidation, and other applications of complex human tissue models. The company also provides liver toxicology predictive screening and research services, as well as works on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at various stages of drug development; and uses its proprietary technologies to build functional 3D human tissues that mimic key aspects of native human tissue composition, architecture, function, and disease. In addition, it offers 3D human tissue platform that develops novel human normal and disease models using high throughput systems, bioprinted, and flow/stretch capable 3D systems. The company was formerly known as Organovo Holdings, Inc. and changed its name to VivoSim Labs, Inc. in April 2025. VivoSim Labs, Inc. was incorporated in 2007 and is headquartered in San Diego, California.

Key metrics

Market cap

$702,006

P/E (TTM)

-0.06

EPS (TTM)

$-4.47

Beta

1.47

Dividend yield

0.00%

Revenue / share

$0.02

50-day avg

$0.55

200-day avg

$1.47

52-week high

$5.30

52-week low

$0.26

CEO

Keith Murphy

ETFs linked to VIVS

Broad-market and Healthcare sector ETFs an investor holding VivoSim Labs is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how VIVS fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze VIVS in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for VivoSim Labs?: VivoSim Labs trades under the ticker VIVS on NASDAQ.
Which exchange is VIVS listed on?: VIVS is listed on NASDAQ.
What sector does VivoSim Labs operate in?: VivoSim Labs is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze VIVS in a portfolio?: PortView shows VIVS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.